Gallic Acid

Gallic Acid

SCHEMBL6754302

O=C(O)c1cc(O)c(O)c(O)c1.O=C(O)c1ccccc1

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CACNA1CCACNA1DCACNA1FCACNA1SDPP4HTR1BHTR1D

The experimentally established mechanism targets of Gallic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 known ✓ P27487 1/20 0.77
CA12 O43570 3/20 0.77
CA1 P00915 3/20 0.77
CA2 P00918 3/20 0.77
CA6 P23280 3/20 0.77
CA9 Q16790 3/20 0.77
KDM4E B2RXH2 2/20 0.77
MAPT P10636 2/20 0.77
CA4 P22748 2/20 0.77
CA7 P43166 2/20 0.77
CA14 Q9ULX7 2/20 0.77
TP53 P04637 2/20 0.77
ALDH1A1 P00352 1/20 0.77
LMNA P02545 1/20 0.77
CA3 P07451 1/20 0.77
SELL P14151 1/20 0.77
HPGD P15428 1/20 0.77
SELP P16109 1/20 0.77
FUT4 P22083 1/20 0.77
MAPK1 P28482 1/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gallic Acid SCHEMBL27613955 0.91 KDM4E (0.77) CA12CA1CA2CA6CA9
Gallic Acid SCHEMBL1455753 0.91 KDM4E (0.77) CA12CA1CA2CA6CA9
Gallic Acid SCHEMBL28275534 0.91 CA12 (0.85) CA12CA1CA2CA6CA9
Gallic Acid SCHEMBL28538292 0.91 CA12 (0.94) CA12CA1CA2CA6CA9
Gallic Acid SCHEMBL26683355 0.89 KDM4E (0.74) CA12CA1CA2CA6CA9
Gallic Acid SCHEMBL17105845 0.89 CA12 (0.74) CA12CA1CA2CA6CA9
Gallic Acid SCHEMBL15012 0.88 CA12 (1.00) CA12CA1CA2CA6CA9
Gallic Acid SCHEMBL1845406 0.88 CA12 (1.00) CA12CA1CA2CA6CA9
Gallic Acid SCHEMBL29484566 0.88 CA12 (1.00) CA12CA1CA2CA6CA9
Gallic Acid SCHEMBL30375631 0.88 CA12 (1.00) CA12CA1CA2CA6CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119013018-A Therapeutic combination comprising ubiquitin-specific processing protease 1 (USP 1) inhibitor and chemotherapeutic agent KSQ治疗公司 2024-11-22 CN disclosed
CN-102549102-B Conductive connecting material, method for connecting terminals, and method for manufacturing connecting terminal SUMITOMO BAKELITE CO.,LTD. (JP) 2014-10-29 CN disclosed
CN-103650114-A Dicing tape-integrated adhesive sheet, semiconductor device, multilayer circuit board, and electronic component SUMITOMO BAKELITE CO 2014-03-19 CN disclosed
CN-102822961-A Circuit board, semiconductor device, method for manufacturing circuit board, and method for manufacturing semiconductor device SUMITOMO BAKELITE CO 2012-12-12 CN disclosed
CN-102576948-A Conductive connecting material and method for connecting terminals using same SUMITOMO BAKELITE CO 2012-07-11 CN disclosed
CN-102549091-A Adhesive film, multilayer circuit board, electronic component, and semiconductor device SUMITOMO BAKELITE CO 2012-07-04 CN disclosed
CN-102473655-A Method for manufacturing electronic component and electronic component SUMITOMO BAKELITE CO 2012-05-23 CN disclosed
JP-2004534057-A Low-poisonous showing oral dosage form of gaba analogue prodrug 2004-11-11 JP disclosed
WO-2001014510-A1 STRIPPING AND CLEANING COMPOSITIONS ASHLAND INC. (US) 2001-03-01 WO disclosed